Astellas Pharma OverviewAstellas Pharma Net Income
Profitability analysis for ALPMY.
Quarterly Net Income
$57.97B
↓ 22.6% YoY
As of Mar 2026
Annual Net Income (TTM)
$229.06B
↑ 351.38% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...